Search Results - E. I. Baranova

New safety standards for anticoagulant therapy in the treatment of atrial fibrillation by E. I. Baranova

Get full text

The Study of Growing Companies as a New Tool of Microeconomic Analysis by E. I. Baranova

Get full text

Dabigatran etexilate in patients with nonvalvular atrial fibrillation: benefits of application in certain clinical situations by E. I. Baranova, Zhanna Kobalava

Get full text

Central directions for reducing cardiovascular mortality: what can be changed today? by E. V. Shlyakhto, E. I. Baranova

Get full text

Personalized approach to the treatment of patients with arterial hypertension: focus on imidazoline receptor agonists. Opinion on the problem by E. I. Baranova, V. Ionin, O. P. Rotar

Get full text

HOW TO REDUCE GASTROINTESTINAL BLEEDING RISK ON ANTICOAGULATION THERAPY IN NON-VALVULAR ATRIAL FIBRILLATION? by E. I. Baranova, А. G. Filatova, V. A. Ionin

Get full text

Antithrombotic therapy for atrial fibrillation and comorbidities — how to choose the optimal solution? by E V Schlyakhto, E I Baranova, V A Ionin

Get full text

Biomarkers of fibrosis and inflammation and the risk of arrhythmia recurrence after elective electrical cardioversion in patients with atrial fibrillation and metabolic syndrome by E. I. Barashkova, V. A. Ionin, E. I. Baranova

Get full text

Hypertension in peri- and postmenopausal women — pathophysiological mechanisms and approaches to treatment by E. I. Baranova, A. A. Katsap, O. S. Kolesnik, E. V. Lebedeva

Get full text

Anticoagulant Therapy in Patients with Non-valvular Atrial Fibrillation in Real Clinical Practice: in Appropriate Dose Reductions by V. A. Ionin, O. I. Bliznuk, E. I. Baranova, E. V. Shlyakhto

Get full text

Factors associated with inappropriate reduced doses of non-vita-min K antagonist oral anticoagulants in patients with atrial fibrillation by V. A. Ionin, O. I. Bliznuk, V. A. Pavlova, E. I. Baranova

Get full text

Paraoxonase 1 gene polymorphisms in patients with type 2 diabetes mellitus by M. V. Kim, S. A. Skoryukova, A. A. Bystrova, E. I. Baranova, S. N. Pchelina

Get full text

Nocturnal hypoxemia, cardiac remodeling, and blood concentrations of fibrosis biomarkers in patients with atrial fibrillation and obstructive sleep apnea by V. A. Berdysheva, V. A. Ionin, A. S. Vakulenko, T. A. Lozovaya, E. I. Baranova

Get full text

Q192R paraoxonase gene 1 (PON1) polymorphism and atorvastatin therapy effect in patients with type 2 diabetes mellitus (T2DM) by M. V. Kim, S. A. Skoryukova, A. A. Bystrova, E. I. Baranova, S. N. Pchelina

Get full text

Clinical features of hypertrophic cardiomyopathy depending on the hereditary factor by V. G. Davydova, A. A. Poliakova, T. G. Bezhanishvili, E. I. Baranova, A. Ya. Gudkova

Get full text

Safety of direct oral anticoagulants in patients with atrial fibrillation and high risk of stroke (review of literature) by E. I. Baranova, V. A. Ionin, A. A. Katsap, O. S. Kolesnik, E. V. Lebedeva

Get full text

Role of peroxisome proliferator-activated receptor α and ϒ-2 in primary and secondary prophylaxis of atherosclerosis by Z. I. Ionova, E. G. Sergeeva, O. A. Berkovich, S. N. Pchelina, E. I. Baranova

Get full text

Apelin and heart remodeling in patients with abdominal obesity by O. V. Listopad, E. A. Bazhenova, V. A. Ionin, O. D. Belyaeva, E. I. Baranova

Get full text

SPECIFICS OF LIPID METABOLISM AND ATORVASTATIN EFFICACY IN TYPE 2 DIABETES WITH CARRIAGE OF VARIOUS POLYMORPHISMS OF CHOLESTEROL ETHER CARRYING PROTEIN TaqIB GENE by M. V. Kim, S. A. Skoryukova, A. A. Bystrova, E. I. Baranova, S. N. Pchelina, E. V. Shlyakhto

Get full text

Reasons for not prescribing anticoagulants in hospitalized patients with atrial fibrillation and high risk of stroke: what should be the optimal management tactics for these patien... by E. I. Baranova, O. I. Bliznyuk, V. A. Pavlova, D. S. Skuridin, O. S. Kolesnik, A. A. Katsap

Get full text